EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Large‐Scale Study Comparing Analytical and Diagnostic Quality of Three HPV Self‐Sampling Devices for At‐Home Cervical Cancer Screening

Alexander Arum iD, Emilie Korsgaard Andreasen, Helle Pedersen, Trine Dahl Nielsen iD, Peter Frandsen, Birgitte Tønnes Pedersen, Estrid Hogdall, Jesper Bonde iD

APMIS · 2025

DOI: 10.1111/apm.70109 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift APMIS, 2025. Verfasst von Alexander Arum und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, afs. 134, AHH-Hvidovre Hospital, Copenhagen University Hospital, Hvidovre, Denmark. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Papillomavirus Infections, Early Detection of Cancer, Specimen Handling. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Intramural funds.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Elimination of cervical cancer requires broad access to and participation in cervical screening. Self‐sampling has emerged as a robust technology that simplifies access; however, few self‐sampling devices are independently validated regarding sample quality. This study compares the quality of three self‐sampling devices: Evalyn (Rovers), currently used in Denmark, the FLOQSwab (Copan) and the modified FLOQSwab: SensiGrip. Women residing in the Capital Region of Denmark, accepting screening by self‐sampling, were offered a kit containing the following combinations of devices: (1) Evalyn, FLOQSwab, (2) Evalyn, SensiGrip or (3) FLOQSwab, SensiGrip. Returned kits were analyzed using the validated BD Onclarity HPV assay on the COR instrument (BD). A total of 1677 women participated. Sample quality was similar across devices, also when stratifying into age groups. Two hundred thirty‐two women (13.9%) tested positive for one or more oncogenic HPV types. Pairwise concordance analysis for each group showed an overall agreement between 93.5% and 95%. Analytical and diagnostic performance of samples collected by the three self‐sampling devices resulted in similar quality and HPV detection. Hence the sample quality is not a determinant in the choice of sampling device and focus on other factors such as cost, women's preference or size and weight can take precedence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsPapillomavirus InfectionsEarly Detection of CancerSpecimen HandlingPapillomaviridaeSelf CareHumansFemaleMiddle AgedAdultDenmarkAgedYoung Adult

Autor:innen und Institutionen

  • Department of Pathology, afs. 134, AHH-Hvidovre Hospital, Copenhagen University Hospital, Hvidovre, Denmark.
  • Department of Pathology, HGH-Herlev Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.

ORCID-Profile: Alexander Arum, Trine Dahl Nielsen, Jesper Bonde

Förderung

  • Intramural funds

Zitieren

APA

Arum, A., Andreasen, E. K., Pedersen, H., Nielsen, T. D., Frandsen, P., Pedersen, B. T., Hogdall, E., & Bonde, J. (2025). Large‐Scale Study Comparing Analytical and Diagnostic Quality of Three HPV Self‐Sampling Devices for At‐Home Cervical Cancer Screening. APMIS. https://doi.org/10.1111/apm.70109

Vancouver

Arum A, Andreasen EK, Pedersen H, Nielsen TD, Frandsen P, Pedersen BT, et al. Large‐Scale Study Comparing Analytical and Diagnostic Quality of Three HPV Self‐Sampling Devices for At‐Home Cervical Cancer Screening. APMIS. 2025. doi:10.1111/apm.70109

BibTeX
@article{Arum2025,
  author = {Arum, Alexander and Andreasen, Emilie Korsgaard and Pedersen, Helle and Nielsen, Trine Dahl and Frandsen, Peter and Pedersen, Birgitte Tønnes and Hogdall, Estrid and Bonde, Jesper},
  title = {Large‐Scale Study Comparing Analytical and Diagnostic Quality of Three HPV Self‐Sampling Devices for At‐Home Cervical Cancer Screening},
  journal = {APMIS},
  year = {2025},
  doi = {10.1111/apm.70109}
}
Kostenlos starten →